Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.25.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XADORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XADENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XADENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XADNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XABORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XABENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XABENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XABNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FT.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XALORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XALENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XALENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XALNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBWORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBWNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
XBF.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
GA.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used